FDA approves next-generation presbyopia-correcting IOLs
The U.S. Food and Drug Administration has approved Tecnis Synergy and Tecnis Synergy Toric II IOLs (Johnson & Johnson Vision), according to a press release.
According to a company-sponsored study, 9 out of 10 patients who received the IOL lenses did not need glasses after surgery.
“The Tecnis Synergy IOL combines the best of extended depth of focus and multifocal technologies – to deliver the widest range of continuous vision with the best near vision among leading [presbyopia-correcting intraocular lens], without the visual gaps caused by existing trifocal technology,” said Rajesh Rajpal, Chief Medical Officer and Global Head of Clinical and Medical Affairs at Johnson & Johnson Vision in the press release. “Additionally, we’ll offer Tecnis Synergy IOL on our new Toric II platform, when it launches later this year, to give surgeons the ability to address astigmatism at the time of surgery.”
Read the full press release here.